Charles Schwab Investment Management Inc Coh Bar, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.09 - $1.49 $94,919 - $129,752	-87,082 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.9 - $1.54 $17,715 - $30,313	19,684 Added 29.21%	87,082 $117,000
Q2 2020 Aug 14, 2020	BUY	$1.08 - $4.0 $56,934 - $210,868	52,717 Added 359.08%	67,398 $105,000
Q2 2019 Aug 09, 2019	SELL	$1.63 - $3.3 $67,645 - $136,950	-41,500 Reduced 73.87%	14,681 $26,000
Q1 2019 May 14, 2019	BUY	$2.95 - $4.16 $43,308 - $61,072	14,681 Added 35.38%	56,181 $184,000
Q3 2018 Nov 13, 2018	SELL	$4.13 - $6.84 $28,472 - $47,154	-6,894 Reduced 14.25%	41,500 $179,000
Q2 2018 Aug 08, 2018	BUY	$4.44 - $10.4 $214,869 - $503,297	48,394 New	48,394 $317,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.28M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.